Emergent Biosolutions
EBS7.4052.56% ( +0.185 )
Emergent Biosolutions (EBS)
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public hea...
- Open
- 7.360
- High
- 7.410
- Low
- 7.200
- Prev. Close
- 7.220
- Volume
- 440.38K
- Turnover
- 3.23M
- Avg Price
- 7.341
- Bid/Ask Ratio
- --
- Amplitude
- 2.91%
- 52wk High
- 14.060
- Volume Ratio
- 0.49
- Turnover Ratio
- 0.89%
Emergent Biosolutions Analyst Rating
View MoreForecast & Rating
Jun 1, 2026Price forecast
$12.0062.93%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Unusual Whales · Jul 22 at 03:03 PM
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
- PUBT · Jul 22 at 03:01 PM
Emergent BioSolutions schedules second-quarter 2026 results conference call
- businessinsider · Jul 15 at 02:40 PM
Emergent's CEO shares what he looks for in developers in the AI era
- PUBT · Jul 14 at 05:02 AM
BlueOne net loss widens to $4.1 million in FY26; revenue rises to $260,013
- PUBT · Jul 2 at 11:58 AM
Emergent BioSolutions SVP Paul Anthony Williams sells 3,000 shares for $25,200
- StockTitan · Jun 29 at 12:13 AM
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government | EBS Stock News
